Skip to main content

Table 1 Characteristics of study participants

From: Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma

  BPD
n = 26
Preterm
n = 23
Asthma
n = 23
Healthy controls
n = 24
Sex, Male/Female 11/15 10/13 10/13 12/12
Age, years 19.6*
(18.2;21.2)
19.1**
(18.3;22.4)
20.2
(18.6;23.3)
20.5
(18.3;23.8)
Weight, kg M/F 69.6/61.5
(48;109.9)/(44.5;88)
68/59.2
(55;85.5)/(44;72.4)
75.7/59
(62;89)/(48;106)
71.8/ 62
(56.5;117.4)/(44.8;112)
Length, cm M/F 175/166
(155;192)/(155;173)
182/165
(169;192)/ (152;173)
174/168
(164;182)/(150;176)
180/167
(168;194)/(151;190)
BMI, m/kg2 M/F 20/22
(18;30)/(18;32)
20/ 21
(17;28)/(17;28)
24/21
(21;29)/(18;34)
21.5/22
(20;33)/(18;38)
FeNO, ppb 14.9
(9.2;22.2)
13.1
(11;19.8)
31.4**
(11.6;49.2)
10.9
(9.7;17.1)
Positive Phadiatop 3 (12) 8 (35) 23 (100) 0
Blood Eosinophils 1 × 102/μL 0.1
(0.0;0.3)
0.0
(0.0;0.2)
0.3***
(0.0;0.7)
0.0
(0.0;0.5)
CRP, mg/L 0.35
(0;2.1)
0.32
(0;1.3)
0.46
(0;7.6)
0.34
(0;7.7)
Alpha-1 antitrypsin g/L 1.4
(0.8;1.7)
1.3
(1.0;1.7)
1.4
(1.1;1.8)
1.4
(1.1;1.9)
Antidepressant medication 1 (3.8) 2 (8.7) 2 (8.7) 1 (4.1)
ADHD/ADD medication 3 (11.5) 3 (13) 0 1 (4.1)
  1. Data are presented as median (range) or numbers (%). Abbreviations: BPD bronchopulmonary dysplasia, M male, F female, BMI body mass index, FeNO fractional exhaled nitric oxide, CRP C-reactive protein, ADHD Attention deficit hyperactivity disorder, ADD Attention deficit disorder
  2. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 (compared to healthy)